Neuroacanthocytosis presenting as parkinsonism.

Mov Disord

Third Department of Neurology, University of Thessaloniki, Greece.

Published: November 2000

Download full-text PDF

Source
http://dx.doi.org/10.1002/1531-8257(200011)15:6<1271::aid-mds1037>3.0.co;2-tDOI Listing

Publication Analysis

Top Keywords

neuroacanthocytosis presenting
4
presenting parkinsonism
4
neuroacanthocytosis
1
parkinsonism
1

Similar Publications

Dilated cardiomyopathy is an expected manifestation and common cause of death in patients with Duchenne muscular dystrophy. We present an unusually rapid progression of cardiomyopathy in a boy with Duchenne muscular dystrophy. Expanded genetic testing revealed a contiguous Xp21 deletion involving dystrophin and XK genes, responsible for Duchenne muscular dystrophy and McLeod neuroacanthocytosis syndrome, respectively, resulting in a more severe cardiac phenotype.

View Article and Find Full Text PDF
Article Synopsis
  • Chorea-Acanthocytosis (ChAc) is a rare genetic disorder characterized by neurodegeneration in the brain and abnormal red blood cells, caused by mutations in the VPS13A gene.
  • The VPS13A protein plays a crucial role in lipid transfer between cell membranes, but its exact function and how its loss leads to the disease symptoms remain unclear.
  • Recent studies are exploring the role of VPS13A in the disease's development and potential biomarkers that could improve understanding and diagnosis of ChAc.
View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on neuroacanthocytosis diseases, specifically a patient presenting with hyperkinetic symptoms linked to genetic variants affecting erythrocyte deformability and acanthocyte presence in blood.
  • A comprehensive assessment was conducted using various methods, including ektacytometry, clinical evaluations, and genetic analysis to understand the patient's condition better and identify potential variants.
  • The findings indicated reduced erythrocyte deformability in the patient with neuroacanthocytosis and revealed a unique ektacytometry pattern that differentiates it from other forms of acanthocytosis.
View Article and Find Full Text PDF

Clinical Features and Novel Pathogenic Variants of Chinese Patients With McLeod Syndrome and Chorea-Acanthocytosis.

Mol Genet Genomic Med

September 2024

Research Centre for Intelligent Healthcare, Faculty of Health and Life Sciences, Coventry University, Coventry, UK.

Article Synopsis
  • The study focuses on McLeod syndrome (MLS) and chorea-acanthocytosis (ChAc), which are rare movement disorders, emphasizing the importance of genetic analysis for proper diagnosis.
  • Eighteen Chinese patients with chorea who tested negative for a specific genetic marker were analyzed using next-generation sequencing, uncovering new genetic variants related to MLS and ChAc.
  • This research expands understanding of the genetic and clinical aspects of these disorders, aiding in the diagnosis and understanding of MLS and ChAc in the Chinese population.
View Article and Find Full Text PDF

Identification of pivotal genes and pathways in Chorea-acanthocytosis using comprehensive bioinformatic analysis.

PLoS One

September 2024

Department of Translational Medicine, Clinical Research Centre, Skåne University Hospital, Lund University, Malmö, Sweden.

Chorea-acanthocytosis (ChAc), an autosomal recessive disorder, is associated with cognitive and behavioral abnormalities. Previous studies were focused around exploring the functional annotation of VPS13A gene in ChAc, whereas the genetic labyrinth underlying this disease and plausible drug targets were underexplored. In the present study, we have identified the pivotal genes and molecular pathways implicated in ChAc using comprehensive bioinformatics analysis.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!